Tatiana A Shnitko1, Sarah C Taylor1, Sierra J Stringfield1,2, Shannon L Zandy3, Roberto U Cofresí3, James M Doherty3, William B Lynch1, Charlotte A Boettiger1,2,4, Rueben A Gonzales3, Donita L Robinson5,6,7. 1. Bowles Center for Alcohol Studies, University of North Carolina, CB #7178, Chapel Hill, NC, 27599-7178, USA. 2. Neurobiology Curriculum, University of North Carolina, Chapel Hill, NC, USA. 3. Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA. 4. Department of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC, USA. 5. Bowles Center for Alcohol Studies, University of North Carolina, CB #7178, Chapel Hill, NC, 27599-7178, USA. DLR@unc.edu. 6. Neurobiology Curriculum, University of North Carolina, Chapel Hill, NC, USA. DLR@unc.edu. 7. Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA. DLR@unc.edu.
Abstract
RATIONALE: Dopamine plays a critical role in striatal and cortical function, and depletion of the dopamine precursors phenylalanine and tyrosine is used in humans to temporarily reduce dopamine and probe the role of dopamine in behavior. This method has been shown to alter addiction-related behaviors and cognitive functioning presumably by reducing dopamine transmission, but it is unclear what specific aspects of dopamine transmission are altered. OBJECTIVES: We performed this study to confirm that administration of an amino acid mixture omitting phenylalanine and tyrosine (Phe/Tyr[-]) reduces tyrosine tissue content in the prefrontal cortex (PFC) and nucleus accumbens (NAc), and to test the hypothesis that Phe/Tyr[-] administration reduces phasic dopamine release in the NAc. METHODS: Rats were injected with a Phe/Tyr[-] amino acid mixture, a control amino acid mixture, or saline. High-performance liquid chromatography was used to determine the concentration of tyrosine, dopamine, or norepinephrine in tissue punches from the PFC and ventral striatum. In a separate group of rats, phasic dopamine release was measured with fast-scan cyclic voltammetry in the NAc core after injection with either the Phe/Tyr[-] mixture or the control amino acid solution. RESULTS: Phe/Tyr[-] reduced tyrosine content in the PFC and NAc, but dopamine and norepinephrine tissue content were not reduced. Moreover, Phe/Tyr[-] decreased the frequency of dopamine transients, but not their amplitude, in freely moving rats. CONCLUSIONS: These results indicate that depletion of tyrosine via Phe/Tyr[-] decreases phasic dopamine transmission, providing insight into the mechanism by which this method modifies dopamine-dependent behaviors in human imaging studies.
RATIONALE: Dopamine plays a critical role in striatal and cortical function, and depletion of the dopamine precursors phenylalanine and tyrosine is used in humans to temporarily reduce dopamine and probe the role of dopamine in behavior. This method has been shown to alter addiction-related behaviors and cognitive functioning presumably by reducing dopamine transmission, but it is unclear what specific aspects of dopamine transmission are altered. OBJECTIVES: We performed this study to confirm that administration of an amino acid mixture omitting phenylalanine and tyrosine (Phe/Tyr[-]) reduces tyrosine tissue content in the prefrontal cortex (PFC) and nucleus accumbens (NAc), and to test the hypothesis that Phe/Tyr[-] administration reduces phasic dopamine release in the NAc. METHODS:Rats were injected with a Phe/Tyr[-] amino acid mixture, a control amino acid mixture, or saline. High-performance liquid chromatography was used to determine the concentration of tyrosine, dopamine, or norepinephrine in tissue punches from the PFC and ventral striatum. In a separate group of rats, phasic dopamine release was measured with fast-scan cyclic voltammetry in the NAc core after injection with either the Phe/Tyr[-] mixture or the control amino acid solution. RESULTS:Phe/Tyr[-] reduced tyrosine content in the PFC and NAc, but dopamine and norepinephrine tissue content were not reduced. Moreover, Phe/Tyr[-] decreased the frequency of dopamine transients, but not their amplitude, in freely moving rats. CONCLUSIONS: These results indicate that depletion of tyrosine via Phe/Tyr[-] decreases phasic dopamine transmission, providing insight into the mechanism by which this method modifies dopamine-dependent behaviors in human imaging studies.
Authors: Christopher D Howard; David P Daberkow; Eric S Ramsson; Kristen A Keefe; Paul A Garris Journal: Eur J Neurosci Date: 2013-04-11 Impact factor: 3.386
Authors: Marco Leyton; Alain Dagher; Isabelle Boileau; Kevin Casey; Glen B Baker; Mirko Diksic; Roger Gunn; Simon N Young; Chawki Benkelfat Journal: Neuropsychopharmacology Date: 2004-02 Impact factor: 7.853
Authors: Tatiana A Shnitko; Kyla D Mace; Kaitlin M Sullivan; W Kyle Martin; Elizabeth H Andersen; Sarah K Williams Avram; Josephine M Johns; Donita L Robinson Journal: Behav Pharmacol Date: 2017-12 Impact factor: 2.293
Authors: Alexander Gómez-A; Tatiana A Shnitko; Haley M Barefoot; Eleanor L Brightbill; Leslie A Sombers; Saleem M Nicola; Donita L Robinson Journal: ACS Chem Neurosci Date: 2018-11-06 Impact factor: 4.418
Authors: Thomas Opladen; Eduardo López-Laso; Elisenda Cortès-Saladelafont; Toni S Pearson; H Serap Sivri; Yilmaz Yildiz; Birgit Assmann; Manju A Kurian; Vincenzo Leuzzi; Simon Heales; Simon Pope; Francesco Porta; Angeles García-Cazorla; Tomáš Honzík; Roser Pons; Luc Regal; Helly Goez; Rafael Artuch; Georg F Hoffmann; Gabriella Horvath; Beat Thöny; Sabine Scholl-Bürgi; Alberto Burlina; Marcel M Verbeek; Mario Mastrangelo; Jennifer Friedman; Tessa Wassenberg; Kathrin Jeltsch; Jan Kulhánek; Oya Kuseyri Hübschmann Journal: Orphanet J Rare Dis Date: 2020-05-26 Impact factor: 4.123
Authors: Giacomo Lazzarino; Valentina Di Pietro; Marco Rinaudo; Zsuzsanna Nagy; Nicholas M Barnes; Lars Bruce; Stefano Signoretti; Renata Mangione; Miriam Wissam Saab; Barbara Tavazzi; Antonio Belli; Giuseppe Lazzarino; Angela Maria Amorini; Ann Logan Journal: Int J Mol Sci Date: 2022-07-30 Impact factor: 6.208
Authors: Amanda Elton; Monica L Faulkner; Donita L Robinson; Charlotte A Boettiger Journal: Neuropsychopharmacology Date: 2021-03-16 Impact factor: 8.294
Authors: Angela Maria Amorini; Giacomo Lazzarino; Valentina Di Pietro; Stefano Signoretti; Giuseppe Lazzarino; Antonio Belli; Barbara Tavazzi Journal: J Cell Mol Med Date: 2016-10-03 Impact factor: 5.310